The current valuation score of Onconetix Inc is 9.80, ranking 4 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 0.00, which is 1171.43% below the recent high of 0.01 and 8093471.43% above the recent low of -56.65.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.